Agilent Highlights Genomics and Cell Analysis Solutions for Cancer Research at AACR 2022

Rhea-AI Summary

Agilent Technologies (NYSE: A) announced advancements in cancer research at the American Association for Cancer Research Annual Meeting in New Orleans from April 8-13, 2022. The company showcased its innovative products like the Agilent Magnis NGS Prep System, allowing rapid assay setups, and the XF Pro Analyzer for live cell monitoring. Agilent's commitment to cancer research aims to support researchers with a comprehensive toolkit for diagnostics and therapeutic development. In fiscal 2021, Agilent generated $6.32 billion in revenue and has a global workforce of 17,000.

Positive

• Showcased innovative cancer research tools at the AACR Annual Meeting.
• Agilent Magnis NGS Prep System streamlines assay setup.
• XF Pro Analyzer enhances live cell monitoring capabilities.
• Demonstrates commitment to supporting global cancer research initiatives.

Negative

• None.

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today announced cancer research innovations in cell analysis and genomics that will be on show at the American Association for Cancer Research Annual Meeting, being held April 8 - 13, 2022 in New Orleans, Louisiana.

“Cancer research is an important focus area for Agilent. The AACR conference presents an exciting opportunity to engage with customers, partners, and thought leaders in this field,” said Jodi Barrientos, vice president of Commercial Marketing for Agilent’s Diagnostics and Genomics Group. “We look forward to highlighting products that enable the analysis of different sample types by leveraging multimodal approaches to cancer research spanning cell analysis, LCMS, and genomics.”

Agilent is committed to helping cancer researchers achieve their scientific objectives by providing a broad toolkit of innovative products and solutions. Furthermore, Agilent’s portfolio of cancer-relevant solutions serves customers globally in their work on cancer research, diagnosis, and therapeutic development.

One of the solutions on show at ACCR is the Agilent Magnis NGS Prep System. This automated benchtop solution has an onboard wizard that allows assays to be set up in under five minutes, enabling molecular pathologists to profile samples for various generic aberrations using a single, cost-effective, and efficient platform.

Also featured will be the Agilent XF Pro Analyzer demonstrating its advanced functionality, particularly its capability to enhance critical aspects of monitoring live cells in real-time. The XF Pro incorporates enhancements that improve measurement performance and data interpretation, making it easier to identify novel drug targets, validate target effect on cellular function, optimize disease models, and determine drug safety and antitumor potential of T cell therapies.

Visit Agilent at booth #1619 to learn more.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in the life sciences, diagnostics, and applied chemical markets, delivering insight and innovation that advance the quality of life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.32 billion in fiscal 2021 and employs 17,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, please subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn, Twitter, and Facebook.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220408005238/en/

Naomi Goumillout

Agilent Technologies

+1.781.266.2819

naomi.goumillout@agilent.com

Source: Agilent Technologies Inc.

FAQ

What innovations did Agilent Technologies showcase at the AACR Annual Meeting 2022?

Agilent showcased the Magnis NGS Prep System and XF Pro Analyzer, focusing on advancements in cancer research.

When is the AACR Annual Meeting where Agilent Technologies is presenting?

The AACR Annual Meeting is being held from April 8-13, 2022, in New Orleans, Louisiana.

What is Agilent Technologies' revenue for fiscal 2021?

Agilent Technologies generated $6.32 billion in revenue for fiscal 2021.

How many employees does Agilent Technologies have?

Agilent Technologies employs approximately 17,000 people worldwide.

What are the focuses of Agilent Technologies in cancer research?

Agilent focuses on diagnostics, therapeutic development, and providing tools for cancer research.